Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Alzheimer'S Research & Therapy|June 29, 2017
Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worseFrédéric Blanc, Rachid Mahmoudi, Thérèse Jonveaux, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
Semantic loss marks early Alzheimer's disease-related neurodegeneration in older adults without dementiaJet M J Vonk, Vincent Bouteloup, Jean-François Mangin, et al.
L'Encephale|April 5, 2025
[Levels of care and training for "ADHD-Specialized Physicians" for Children and Adolescents in France in 2024]Thiébaut-Noël Willig, Stéphanie Bioulac, Jean-Paul Blanc, et al.
Journal of Alzheimer'S Disease : JAD|September 3, 2016
Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory CentersEloi Magnin, Jean-François Démonet, David Wallon, et al.
Journal of Alzheimer'S Disease : JAD|September 26, 2025
Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohortDany Mukesha, Maité Sarter, Mélitine Dubray, et al.
Alzheimer'S Research & Therapy|December 6, 2014
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profilesSylvain Lehmann, Julien Dumurgier, Susanna Schraen, et al.
Current Alzheimer Research|January 11, 2018
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF BiomarkersOlivier Vercruysse, Claire Paquet, Audrey Gabelle, et al.
Acta Neuropathologica|June 7, 2021
Clinical and neuropathological diversity of tauopathy in MAPT duplication carriersDavid Wallon, Susana Boluda, Anne Rovelet-Lecrux, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective studyThéodore Decaix, François Mouton-Liger, Julien Dumurgier, et al.
Pageof 8